• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about FATE

Recent news which mentions FATE

< Previous 1 2 3 4 5 Next >
Benzinga's Top Ratings Upgrades, Downgrades For June 3, 2022
June 03, 2022
Tickers ADPT AGLE ALLO AON
Tags MARA ARAV POR
From Benzinga
‘The capitulation model for biotech is a Category 5 storm, the same as energy in 2020’ — why contrarians say the sector is a buy
May 20, 2022
Tickers BMY FATE IBB JNJ
Tags UCBJY VTYX OLMA
From MarketWatch
Recap: Fate Therapeutics Q1 Earnings
May 04, 2022
Tickers FATE
Tags Earnings BZI/Recaps Market News
From Benzinga
The Daily Biotech Pulse: Kezar Life's Lead Asset Fails, Brickell Biotech Offloads Late-Stage Asset, Connect Biopharma Ulcerative Colitis Trial Disappoints
May 04, 2022
Tickers AGTC ALLO ALNA AMRN
Tags MCRB RAIN APLS
From Benzinga
These stocks soared during the pandemic, and then crashed. Ten are now expected to double in price.
May 02, 2022
Tickers APPN ARKK BILI BLDP
Tags FTCH BLDP CHWY
From MarketWatch
What 4 Analyst Ratings Have To Say About Fate Therapeutics
March 04, 2022
Tickers FATE
Tags Analyst Ratings Market News FATE
From Benzinga
Fate Therapeutics: Q4 Earnings Insights
February 28, 2022
Tickers FATE
Tags FATE Benzinga BZI/Recaps
From Benzinga
Earnings Scheduled For February 28, 2022
February 28, 2022
Tickers AAON ACAD ACHC AGM
Tags BLNK PRAA ACHC
From Benzinga
The Week Ahead In Biotech (Feb. 27-March 5): Earnings, Multiple Regulatory Decisions Take The Spotlight
February 27, 2022
Tickers ACAD ACLX AMRN AMRS
Tags NVCT CTIC HRTX
From Benzinga
Fate Therapeutics's Earnings: A Preview
February 25, 2022
Tickers FATE
Tags Benzinga FATE Earnings
From Benzinga
Earnings Outlook For Fate Therapeutics
February 25, 2022
Tickers FATE
Tags Benzinga FATE Earnings
From Benzinga
2 Natural-Killer Cell Therapy Oncology Companies Investors Should Watch
February 08, 2022
Tickers BMY FATE IPSC
Tags Analyst Ratings Market News Analyst Color
From Benzinga
Benzinga Asks: Which ARK Fund Would You Rather Buy And Hold For 5 Years?
January 14, 2022
Tickers ARKF ARKG ARKK ARKW
Tags EXAS ARKK Specialty ETFs
From Benzinga
Here's How Much $100 Invested In Fate Therapeutics 5 Years Ago Would Be Worth Today
January 05, 2022
Tickers FATE
Tags Benzinga FATE BZI/POD
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 15, 2021
December 15, 2021
Tickers ADGI ALB AMCR APEN
Tags MAX JKHY HUN
From Benzinga
10 Biggest Price Target Changes For Wednesday
December 15, 2021
Tickers ADGI BKNG EW FATE
Tags Pre/Market Outlook Analyst Ratings Market News
From Benzinga
The Daily Biotech Pulse: Mesoblast, Novartis Sever COVID-19 Treatment Partnerships, Sigilon To Reduce Workforce, ASH Presentations Move Stocks
December 14, 2021
Tickers APTO ATRA AZN BLU
Tags IBB CLSD VACC
From Benzinga
Fate Therapeutics Showcases Interim Data From FT596 Cell Program In Lymphoma
December 14, 2021
Tickers FATE
Tags Health Care Briefs Movers
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 7, 2021
December 07, 2021
Tickers APD APPS ARVN AZN
Tags SFT MRK CMCO
From Benzinga
Cathie Wood Likes Fate Therapeutics, Should You?
December 01, 2021
Tickers FATE TWST
Tags FATE TWST Market News
From Motley Fool
3 Biotech Stocks That Can Double Your Money, According to Wall Street
November 25, 2021
Tickers ADPT AXSM FATE
Tags FATE AXSM Market News
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For November 9, 2021
November 09, 2021
Tickers ADCT ADMA AQB BPOP
Tags LTHM ADMA Analyst Ratings
From Benzinga
Fate Therapeutics, inc (FATE) Q3 2021 Earnings Call Transcript
November 05, 2021
Tickers FATE
Tags Market News Recent Press Releases FATE
From Motley Fool
The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO
November 04, 2021
Tickers AERI ALGS ALLO ANIP
Tags GKOS ARNA AXNX
From Benzinga
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
October 31, 2021
Tickers ADPT AERI AGIO ALGS
Tags ETON FATE NVAX
From Benzinga
3 Biotech Stocks to Watch Now
October 12, 2021
Tickers ACAD FATE PIRS
Tags contributors Penny Stocks PIRS
From Benzinga
Recent Poor Results Have Made This Promising Cathie Wood Pick a Bargain
September 14, 2021
Tickers ARKG ARKK FATE
Tags FATE ARKG Market News
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For August 26, 2021
August 26, 2021
Tickers AFCG ALLK APPH AY
Tags CPNG APPH Analyst Ratings
From Benzinga
58 Biggest Movers From Friday
August 23, 2021
Tickers AMRS ARAY ARCE ATER
Tags Movers From Yesterday FLGC SABR
From Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
August 20, 2021
Tickers ALLO AXDX ENDP ENSC
Tags GOVX Market News XTLB
From Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap